FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE and GASTROOESOPHAGEAL REFLUX DISEASE

Overview

GASTROOESOPHAGEAL REFLUX DISEASE is the #7 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, manufactured by HyVee Inc. There are 15 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE to GASTROOESOPHAGEAL REFLUX DISEASE. This represents approximately 2.5% of all 604 adverse event reports for this drug.

Patients taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE who experience gastrooesophageal reflux disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

GASTROOESOPHAGEAL REFLUX DISEASE is a less commonly reported adverse event for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, but still significant enough to appear in the safety profile.

Other Side Effects of FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE

In addition to gastrooesophageal reflux disease, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE:

• DRUG INEFFECTIVE — 70 reports
• CHRONIC KIDNEY DISEASE — 53 reports
• DRUG EFFECT LESS THAN EXPECTED — 28 reports
• RENAL FAILURE — 27 reports
• ACUTE KIDNEY INJURY — 23 reports
• OFF LABEL USE — 22 reports
• END STAGE RENAL DISEASE — 14 reports
• EXPIRED PRODUCT ADMINISTERED — 14 reports
• NAUSEA — 12 reports
• WRONG TECHNIQUE IN PRODUCT USAGE PROCESS — 12 reports

Other Drugs Associated with GASTROOESOPHAGEAL REFLUX DISEASE

The following drugs have also been linked to gastrooesophageal reflux disease in FDA adverse event reports:

Does FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE cause GASTROOESOPHAGEAL REFLUX DISEASE?

GASTROOESOPHAGEAL REFLUX DISEASE has been reported as an adverse event in 15 FDA reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is GASTROOESOPHAGEAL REFLUX DISEASE with FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE?

GASTROOESOPHAGEAL REFLUX DISEASE accounts for approximately 2.5% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, making it a notable side effect.

What should I do if I experience GASTROOESOPHAGEAL REFLUX DISEASE while taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE?

If you experience gastrooesophageal reflux disease while taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages